Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
AssigneeBaxter International Inc.
InventorsRichard Cotter, Robert C. Johnson, Michael Ward, David C. Madsen, Anthony J. Valicenti, Michael P. Menard, Hugh N. Tucker
Life of this patent
Estimating the term…
Abstract
A method is provided for individuals under treatment for or at risk of atherosclerotic, vascular, cardiovascular, and/or thrombotic disease by administering a composition which comprises a protein source; a carbohydrate source; and at least one lipid selected from the group consisting of: gamma-linolenic acid; eicosapentaenoic acid; docosahexaenoic acid; sterodonic acid; and linolenic acid. Both an enteral and parenteral composition are provided.
Claims14
A method for providing cardiac therapy to an individual in need of same through a parenteral regimen comprising:
- a. a therapeutically effective amount of a protein source which includes a high biological value protein, amino acids including branched-chain amino acids and L-carnitine;
- b. a therapeutically effective amount of a polysaccharide source supplemented with ribose and/or xylitol;
- and
- c. a therapeutically effective amount of a lipid emulsion consistently essentially of a natural oil containing unsaturated fatty acids of 11 to 26 carbons in length, and an emulsifier.
A method of providing cardiac therapy to an individual in need of same utilizing an enteral regimen comprising:
- a. a therapeutically effective amount of a protein source which includes a high biological value protein, amino acids including branched-chain amino acids and L-carnitine;
- b. a therapeutically effective amount of a polysaccharide source supplemented with ribose and/or xylitol;
- and
- c. a therapeutically effective amount of a lipid emulsion consistently essentially of a natural oil containing unsaturated fatty acids of 11 to 26 carbons in length, and an emulsifier.
A method for providing therapy to an individual at risk or under treatment for vascular, cardiovascular, or thrombotic diseases comprising the steps of:
- a. administering a therapeutically effective amount of a protein source which includes a high biological value protein, amino acids including branched-chain amino acids and L-carnitine;
- b. administering a therapeutically effective amount of a polysaccharide source supplemented with ribose and/or xylitol;
- and
- c. administering a therapeutically effective amount of a lipid emulsion consistently essentially of a natural oil containing unsaturated fatty acids of 11 to 26 carbons in length, and an emulsifier.
Dependencies are inferred from the claim text.